American Journal of Cardiology
Volume 103, Issue 9 , Pages 1196-1203, 1 May 2009

Impact of Gender and Antithrombin Strategy on Early and Late Clinical Outcomes in Patients With Non–ST-Elevation Acute Coronary Syndromes (from the ACUITY Trial)

  • Alexandra J. Lansky, MD

      Affiliations

    • Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York
    • Corresponding Author InformationCorresponding author: Tel: 212-851-9320; fax: 212-851-9321
    • ,
  • Roxana Mehran, MD

      Affiliations

    • Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York
    • ,
  • Ecatarina Cristea, MD

      Affiliations

    • Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York
    • ,
  • Helen Parise, ScD

      Affiliations

    • Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York
    • ,
  • Frederick Feit, MD

      Affiliations

    • New York University School of Medicine, New York, New York
    • ,
  • E. Magnus Ohman, MD

      Affiliations

    • Department of Medicine, Duke University School of Medicine, Durham, North Carolina
    • ,
  • Harvey D. White, MD

      Affiliations

    • Green Lane Cardiovascular Service, Auckland City Hospital, Auckland, New Zealand
    • ,
  • Karen P. Alexander, MD

      Affiliations

    • Department of Medicine, Duke University School of Medicine, Durham, North Carolina
    • ,
  • Michel E. Bertrand, MD

      Affiliations

    • Hopital Cardiologique, Lille, France
    • ,
  • Walter Desmet, MD

      Affiliations

    • University Hospital Gasthuisberg, Leuven, Belgium
    • ,
  • Martial Hamon, MD

      Affiliations

    • University Hospital, Normandy, France
    • ,
  • Gregg W. Stone, MD

      Affiliations

    • Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York

Received 3 December 2008; received in revised form 8 January 2009; accepted 8 January 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 The ACUITY trial was sponsored by The Medicines Company, Parsippany, NJ.

PII: S0002-9149(09)00125-8

doi:10.1016/j.amjcard.2009.01.030

American Journal of Cardiology
Volume 103, Issue 9 , Pages 1196-1203, 1 May 2009

Article Tools

* Image Usage & Resolution